- COUNTERPOINT - Both Immunohistochemistry and Fluorescence In Situ Hybridization Play Important Roles for HER2 Evaluation

被引：3

作者：

Bloom, Kenneth J. ^{[1
]}

Cote, Richard J. ^{[2
,3
]}

机构：

[1] Clarient Inc, Aliso Viejo, CA 92629 USA

[2] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA

[3] Univ Miami, Miller Sch Med, Biomed Nanosci Inst, Miami, FL 33136 USA

来源：

CLINICAL CHEMISTRY | 2011年 / 57卷 / 07期

关键词：

BREAST-CANCER;

D O I：

10.1373/clinchem.2010.160853

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：983 / 985

页数：3

共 11 条

[1] Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy [J].

Bloom, K ;

Harrington, D .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (05) :620-630

[2] Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification [J].

Brunelli, Matteo ;

Manfrin, Erminia ;

Martignoni, Guido ;

Miller, Keith ;

Remo, Andrea ;

Reghellin, Daniela ;

Bersani, Samantha ;

Gobbo, Stefano ;

Eccher, Albino ;

Chilosi, Marco ;

Bonetti, Franco .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (05) :678-682

[3] HER2 testing in the UK: consensus from a national consultation [J].

Dowsett, M. ;

Hanby, A. M. ;

Laing, R. ;

Walker, R. .

JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (06) :685-689

[4] Delay to formalin fixation effect on breast biomarkers [J].

Khoury, Thaer ;

Sait, Sheila ;

Hwang, Helena ;

Chandrasekhar, Rameela ;

Wilding, Gregory ;

Tan, Dongfeng ;

Kulkarni, Swati .

MODERN PATHOLOGY, 2009, 22 (11) :1457-1467

[5] Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis [J].

Marchio, Caterina ;

Lambros, Maryou B. ;

Gugliotta, Patrizia ;

Di Cantogno, Ludovica Verdun ;

Botta, Cristina ;

Pasini, Barbara ;

Tan, David S. P. ;

Mackay, Alan ;

Fenwick, Kerry ;

Tamber, Narinder ;

Bussolati, Gianni ;

Ashworth, Alan ;

Reis-Filho, Jorge S. ;

Sapino, Anna .

JOURNAL OF PATHOLOGY, 2009, 219 (01) :16-24

[6] Real-world performance of HER2 testing - National surgical adjuvant breast and bowel project experience [J].

Paik, S ;

Bryant, J ;

Tan-Chiu, E ;

Romond, E ;

Hiller, W ;

Park, K ;

Brown, A ;

Yothers, G ;

Anderson, S ;

Smith, R ;

Wickerham, DL ;

Wolmark, N .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (11) :852-854

[7] HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial [J].

Perez, Edith A. ;

Reinholz, Monica M. ;

Hillman, David W. ;

Tenner, Kathleen S. ;

Schroeder, Matthew J. ;

Davidson, Nancy E. ;

Martino, Silvana ;

Sledge, George W. ;

Harris, Lyndsay N. ;

Gralow, Julie R. ;

Dueck, Amylou C. ;

Ketterling, Rhett P. ;

Ingle, James N. ;

Lingle, Wilma L. ;

Kaufman, Peter A. ;

Visscher, Daniel W. ;

Jenkins, Robert B. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) :4307-4315

[8] Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response [J].

Reinholz, Monica M. ;

Bruzek, Amy K. ;

Visscher, Daniel W. ;

Lingle, Wilma L. ;

Schroeder, Matthew J. ;

Perez, Edith A. ;

Jenkins, Robert .

LANCET ONCOLOGY, 2009, 10 (03) :267-277

[9] Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831 [J].

Roche, PC ;

Suman, VJ ;

Jenkins, RB ;

Davidson, NE ;

Martino, S ;

Kaufman, PA ;

Addo, FK ;

Murphy, B ;

Ingle, JN ;

Perez, EA .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (11) :855-857

[10] Assessment of HER2 Gene Status in Breast Carcinomas With Polysomy of Chromosome 17 [J].

Vranic, Semir ;

Teruya, Bryan ;

Repertinger, Susan ;

Ulmer, Pamela ;

Hagenkord, Jill ;

Gatalica, Zoran .

CANCER, 2011, 117 (01) :48-53

← 1 2 →